| Unique ID issued by UMIN | UMIN000022240 |
|---|---|
| Receipt number | R000025622 |
| Scientific Title | An examination of the effective group Acceptance and Commitment Therapy of Irritable bowel syndrome symptoms for university students |
| Date of disclosure of the study information | 2016/05/10 |
| Last modified on | 2017/04/25 14:44:00 |
An examination of the effective group Acceptance and Commitment Therapy of Irritable bowel syndrome symptoms for university students
The examination of the effective group Acceptance and Commitment Therapy of Irritable bowel syndrome
An examination of the effective group Acceptance and Commitment Therapy of Irritable bowel syndrome symptoms for university students
The examination of the effective group Acceptance and Commitment Therapy of Irritable bowel syndrome
| Japan |
Irritable bowel syndrome
| Hepato-biliary-pancreatic medicine | Psychiatry | Adult |
Others
NO
The purpose of this study is whether group Acceptance and Commitment Therapy for university students could demonstrare significant decrease in irritable bowel syndrome severity score.
Efficacy
Irritable bowel syndrome severity index
The Japanese version of the irritable bowel syndrome quality of life instrument (IBS-QOL-J)
Medical Outcome Study 36-item Short Form Health Survey (SF-36)
1.Beck Depression Inventory-Second Edition (BDI-2)
2.State Trait Anxiety Inventory (STAI)
3. The Japanese version of the Acceptance and Action Questionnaire-II
4. The Japanese version of the Cognitive Fusion Questionnaire
5. The Japanese version of the Five Facet Mindfulness Questionnaire
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Educational,Counseling,Training
| Behavior,custom |
1-day session of group Acceptance and Commitment Therapy for Irritable bowel syndrome
Waiting
| 18 | years-old | <= |
| 50 | years-old | > |
Male and Female
1.The score of IBSSI >= 75 at the screening
2.Ability to both understand and agree
with informed consent in Japanese
1.Participants who presently undergoing psychopharmacological, or psychological treatment for gastrointestinal or psychiatric disorder
2.Person in whom organic disease is suggested by the presence of warning symptom (anemia, inflammatory reactions, or fecal occult blood, Unexplained weight loss in past 6 months, Persons with a family history of colon cancer)
3.Persons observed to have significant suicidal ideation
4.Any other person whom the principal investigator has determined to be unsuitable as a participant of the study
70
| 1st name | |
| Middle name | |
| Last name | Takashi Muto |
Doshisha university
Faculty of psychology
1-3 Miyakodani, Tatara, Kyotanabe, Kyoto
0774658220
takamuto@mail.doshisha.ac.jp
| 1st name | |
| Middle name | |
| Last name | Masataka Ito |
Doshisha university
Faculty of psychology
1-3 Miyakodani, Tatara, Kyotanabe, Kyoto
0774658220
ekq1003@mail2.doshisha.ac.jp
Doshisha University
Doshisha University
Other
Japan
NO
| 2016 | Year | 05 | Month | 10 | Day |
Unpublished
Completed
| 2016 | Year | 05 | Month | 10 | Day |
| 2016 | Year | 05 | Month | 12 | Day |
| 2016 | Year | 05 | Month | 08 | Day |
| 2017 | Year | 04 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025622